Latest Market News

May 27
Two key takeaways from Nansen’s UST stablecoin depeg report

As the dust settles on the cataclysmic collapse of the Terra ecosystem, an on-chain deep-dive carried out by blockchain analytics firm Nansen highlights two major takeaways. The cryptocurrency ecosystem was awash with varying speculatory theories around the cause of Terra’s algorithmic stablecoin UST’s decoupling from its $1 peg. The who and why seemed a mystery […]

May 27
Canopy Growth shares drop on wider-than-expected loss

Canopy Growth Corp. CGC, +10.34% WEED, +10.56% shares fell 11% in premarket trades Friday after it said its fourth-quarter loss narrowed to C$574.6 million, or $1.46 a share, from C$700 million, or $1.85 a share in the year-ago quarter. Revenue for the three months ended March 31 fell to C$126.1 million from C$167.4 million in […]

May 27
Trulieve Cannabis CEO buys $202,300 worth of stock

Trulieve Cannabis TCNNF, +3.74% CEO Kim Rivers acquired 14,000 shares of the cannabis company on Tuesday at a price of $14.45 a share for a total purchase value of about $202,300, according to a filing. Rivers now owns just under 2.5 million shares. Trulieve CFO Alex D’Amico acquired 1,500 shares and Trulieve president Steve White […]

May 27
JPMorgan trials blockchain for collateral settlement in after-hours trading

“What we’ve achieved is the friction-less transfer of collateral assets on an instantaneous basis,” stated JPMorgan’s global head of trading services Ben Challice. 1609 Total views 29 Total shares Multinational investment bank JPMorgan Chase & Co is reportedly trialing the use of its own private blockchain for collateral settlements. According to Bloomberg, JPMorgan conducted a […]

May 27
FDA grants priority review to Reata’s rare disease drug

Shares of Reata Pharmaceuticals Inc. RETA, +3.42% were up 2.4% in trading on Thursday after the company said the Food and Drug Administration granted priority review to the company’s experimental treatment for Friedreich’s ataxia, a rare nervous system disease. The regulator is now set to make a decision on omaveloxolone by Nov. 30. “If approved, […]

May 27
EURO FX FUTURES (6E1!), H1 Potential For Bullish Moment

Type: Bullish MomentumKey Levels:Resistance: 1.07570Pivot: 1.06715Support: 1.06155Preferred Case:With the MACD having a bullish momentum and prices breaking the ichimoku cloud , which supports our bullish bias that price will rise from our pivot at 1.06715 in line with overlap support to our 1st resistance at 1.07570 where the 61.8% fibonacci projection and swing high resistance […]